|1.||Murray, F Jay: 2 articles (11/2015 - 01/2011)|
|2.||Hosako, Hiromi: 1 article (11/2015)|
|3.||Harkema, Jack R: 1 article (11/2015)|
|4.||Wasil, Jennifer M: 1 article (11/2015)|
|5.||Cruzan, George: 1 article (11/2015)|
|6.||Haseman, J K: 1 article (06/2013)|
|7.||National Toxicology Program: 1 article (01/2007)|
|8.||National Toxicology Program, US Department of Health and Human Services, Public Health Service, National Institutes of Health: 1 article (04/2004)|
|9.||Chan, P C: 1 article (04/2004)|
|1.||Body Weight (Weight, Body)
01/01/2007 - "2-YEAR STUDY IN MICE: Groups of 50 male and 50 female mice were fed diets containing 0, 312, 625, or 1,250 ppm 4-methylimidazole (equivalent to average daily doses of approximately 40, 80, and 170 mg 4-methylimidazole/kg body weight to males and females) for 106 weeks. "
01/01/2007 - "2-YEAR STUDY IN RATS: Groups of 50 male and 50 female rats were fed diets containing 0, 625, 1,250, or 2,500 ppm 4-methylimidazole (males) or 0, 1,250, 2,500, or 5,000 ppm 4-methylimidazole (females) (equivalent to average daily doses of approximately 30, 55, or 115 mg 4-methylimidazole/kg body weight to males and 60, 120, or 260 mg/kg to females) for 106 weeks. "
04/01/2004 - "In the 14-week 4-methylimidazole studies, one 10,000 ppm male mouse was found dead during week 4, and seven 10,000 ppm female mice were found dead during weeks 1 and 2. Mean body weights were significantly less than those of the controls for male rats exposed to 2,500 ppm or greater, 5,000 and 10,000 ppm female rats, male mice exposed to 1,250 ppm or greater, and all exposed groups of female mice. "
04/01/2004 - "In the 4-methylimidazole studies, all animals survived to the end of the studies, and there were no significant differences in mean body weights, clinical findings, organ weights, or gross or microscopic lesions between exposed and control groups. "
01/01/2007 - "Under the conditions of these 2-year studies, there was no evidence of carcinogenic activity of 4-methylimidazole in male F344/N rats exposed to 625, 1,250, or 2,500 ppm. There was equivocal evidence of carcinogenic activity of 4-methylimidazole in female F344/N rats based on increased incidences of mononuclear cell leukemia. "
11/01/2015 - "Evaluation of the mode of action of mouse lung tumors induced by 4-methylimidazole."
06/01/2013 - "The potential carcinogenicity of 4-methylimidazole (4-MEI) was evaluated in a National Toxicology Program (NTP) rodent cancer bioassay in Fischer 344 rats and B6C3F1 mice (NTP, 2007; Chan et al., 2008). "
01/01/2011 - "Does 4-methylimidazole have tumor preventive activity in the rat?"
01/01/2007 - "There was clear evidence of carcinogenic activity of 4-methylimidazole in male and female B6C3F1 mice based on increased incidences of alveolar/bronchiolar neoplasms. "